title: The A1C Prandial Product: An objective tool to decision making in diabetes.
abstract: This brief article describes a numerical index designed to assess the relative contribution of fasting and postprandial glucose to hyperglycaemia. This helps plan appropriate insulin and oral glucose-lowering therapy in an objective manner. It also reviews three similar indices described earlier in literature. Such indices need to be validated in large, multicentric trials, and have the potential to bring objectivity to choice of treatment of diabetes.
authors.affiliation: Department of Endocrinology, Bharti Hospital & BRIDE, Karnal, India.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kalra
authors.affiliation: Department of Medicine, Government Medical College, Chandigarh, India.
authors.forename: Yashdeep
authors.initials: Y
authors.lastname: Gupta
authors.affiliation: Department of Endocrinology, Excel Hospitals, Guwahati, India.
authors.forename: Manash
authors.initials: M
authors.lastname: P Baruah
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy; D016903:Drug Monitoring / Q000379:methods*; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects; D054539:Medication Therapy Management
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin
keywords: Diabetes, insulin, oral hypoglycaemic agents, basal insulin, prandial insulin, postprandial hyperglycaemia.